PAPER Zhao Y, Zheng X, Wang Q, Xu J, Xu X, Zhang M
SEARCH RESULTS
330006 RESULTS
PAPER Daviet JC, Roy X, Quelven-Bertin I, Jallageas R, Mandigout S, Torny F, Monteil J
Parkinson's patient runs an ultra marathon: a case report.
Eur J Phys Rehabil Med. 2014 Mar 5; PubMed: 24594852PAPER Vedam-Mai V, Gardner B, Okun MS, Siebzehnrubl FA, Kam M, Aponso P, Steindler DA, Yachnis AT, Neal D, Oliver BU, Rath SJ, Faull RL, Reynolds BA, Curtis MA
Increased precursor cell proliferation after deep brain stimulation for Parkinson's disease: a human study.
PLoS One. 2014;9(3):e88770. Epub 2014 Mar 3 PubMed: 24594681PAPER Weiduschat N, Mao X, Beal MF, Nirenberg MJ, Shungu DC, Henchcliffe C
Sex differences in cerebral energy metabolism in Parkinson's disease: a phosphorus magnetic resonance spectroscopic imaging study.
Parkinsonism Relat Disord. 2014 May;20(5):545-8. Epub 2014 Feb 13 PubMed: 24593902PAPER Geevarghese R, Lumsden DE, Hulse N, Samuel M, Ashkan K
Subcortical Structure Volumes and Correlation to Clinical Variables in Parkinson's Disease.
J Neuroimaging. 2014 Mar 5; PubMed: 24593221PAPER Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease.
Ann Neurol. 2005 Dec;58(6):963-7. PubMed: 16240369PAPER Meyer U, Feldon J, Yee BK
A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.
Schizophr Bull. 2009 Sep;35(5):959-72. Epub 2008 Apr 11 PubMed: 18408229PSEN1 A275V
MUTATIONS PSEN1 73664793 GRCh37/hg19 C T Exon 8 Point, Missense Coding Increased the Aβ42/Aβ40 ratio and decreased the Aβ (37 + 38 + 40) / (42 + 43) ratio. Neuropathology consistent with AD. A275V Alzheimer's Disease: PathogenicAlzheimer's Disease This mu
Mindy Brown
South Orange, United States
APP
ANTIBODY polyclonal manufacturer Synthetic peptide GYENPTYKFFEQMQN corresponding to the C-terminus of APP coupled to key-hole limpet hemocyanin via an added N-terminal cysteine residue. antiserum, lyophilized. Specific for APP. Confirmed available March 2014 127 0
Tau
ANTIBODY polyclonal manufacturer Recombinant mouse tau (amino acids 3- 214). antiserum, lyophilized. The antibody binds phosphorylated and non-phosphorylated tau proteins. no signal in zebrafish; other species not tested yet. Confirmed available March 2014 314 002
Tau (248E5)
ANTIBODY monoclonal 248E5 manufacturer Recombinant mouse tau (amino acids 3- 214) Purified IgG, lyophilized. Azide was added before lyophilization. Unconjugated. The antibody binds phosphorylated and non-phosphorylated tau proteins. WB: Detects the mouse protein w
World Conference of the Society for Brain Mapping and Therapeutics, 2014
CONFERENCE 2014-03-17 00:00:00-2014-03-19 00:00:00 Four Seasons Hotel, Sydney, Australia 17 March 2014 to 19 March 2014 View Conference Website 0
John Corbell
Kato Haruhiko
Current Filters
No filters selected